Abbreviations used: APEX1 -APEX nuclease 1; BER -base excision repair; BMI -body mass index; FECD -Fuchs endothelial corneal dystrophy; KC -keratoconus; PCR-RFLP -polymerase chain reaction restriction fragment length polymorphism; ROS -reactive oxygen species Abstract: Human APEX nuclease 1 (APEX1) plays an important role in the repair of oxidative DNA lesions through base excision repair. It may influence the development of oxidative stress-related diseases. The aim of this study was to determine the relationship between the genotypes of the c.444 T>G (rs1130409) and c.-468 T>G (rs1760944) polymorphisms in the APEX1 gene and the occurrence of two oxidative stress-related eye diseases: keratoconus (KC) and Fuchs endothelial corneal dystrophy (FECD). The study involved 250 patients with KC, 209 patients with FECD, and 350 control subjects. All of the patients and control subjects underwent a detailed ophthalmic examination. The polymorphisms were genotyped by mismatch polymerase chain reaction restriction fragment length polymorphism (mismatch PCR-RFLP). We observed that the G/T and T/T genotypes of the c.-468 T>G polymorphism were respectively associated with a decreased occurrence of KC (OR 0.54, 95% CI 0.37-0.95; p = 0.030) and an increased occurrence of KC (OR 1.87, 95% CI 1.06-3.32; p = 0.032). None of these polymorphisms showed any association CELLULAR & MOLECULAR BIOLOGY LETTERS 49 with FECD. Furthermore, no other association was observed, including haplotypes of the two polymorphisms. Our findings suggest that the c.-468 T>G polymorphism of the APEX1 gene may play a role in the pathogenesis of KC.
INTRODUCTION
Keratoconus (KC, OMIM #148300) is an eye disease in which the cornea takes a conical shape as a result of progressive thinning and protrusion [1] . Clinical signs of this disease include a decrease in visual acuity and image distortion due to the presence of irregular astigmatism and/or myopia. Moreover, KC may be associated with photophobia, glare and ocular itching [2] . KC usually begins in adolescence or early adulthood and progresses until the third or fourth decade of life [3] . Typically, KC is a bilateral disease, but changes in one eye can arise earlier than in the other eye. The pathogenesis of KC is not precisely known, but genetic and environmental factors are possibly associated with its onset and progression [4, 5] . Although it is classified as sporadic in most cases, a significant number of patients have a positive familial history [5] . Results of familial studies indicated a 15-to 67-times higher prevalence of KC in firstdegree relatives than in the general population [6] . Moreover, several twin studies reported a higher concordance of KC in monozygotic than in dizygotic twins, supporting the hypothesis of the role of genetic factors in the etiology of the disease [7] . Genome-wide linkage analyses have identified several susceptibility loci for KC, including 1p36, 2p24, 3p14-q13, 5q14-q21, 8q13-q21, 13q32, 15q22-q24, 16q22-q23 and 20q12 [8] [9] [10] [11] [12] [13] [14] [15] . Despite this extensive research, only a few genes associated with KC have been identified in these regions, including the DOCK9 (dedicator of cytokinesis 9) gene, which is located at 13q32, and miR-184, which is positioned at 15q22-q25 [16] . Causal mutations were also identified in the VSX1 (visual system homeobox 1) gene at 20p11. 21 , SOD1 (superoxide dismutase 1) gene at 21q22.11, LOX gene at 5q23.2, IL-1B (interleukin 1β) gene at 2q14, and in the collagen genes COL4A3 (collagen type IV, alpha 3) at 2q36-q37 and COL4A4 (collagen type IV, alpha 4) at 2q35-q37 [16] . Fuchs endothelial corneal dystrophy (FECD, OMIM #136800) is another corneal disease. It is characterized by the loss of endothelial cells, changes in endothelial cell morphology, and concomitant formation of excrescences termed guttae growing from Descemet's membrane [17, 18] . Due to these irregularities in the inner corneal layers, the cornea loses its transparency, resulting in decreased visual acuity and ultimately blindness [19] . Two forms of the disease can be distinguished -the rare early-onset FECD, which is generally begins in the third decade of life, and the more common late-onset form that usually develops in the fourth and fifth decades [20] . FECD pathogenesis is not well understood, but a growing body of evidence suggests that it is a multifactorial disease with both genetic and environmental aspects [19, 21] . One of the first genes associated with early-onset FECD was COL8A2 [18, 22] . This gene encodes the alpha 2 subtype of collagen VIII, which is a major component of Descemet's membrane. Linkage analyses in large multigenerational families detected four chromosomal risk loci for late-onset FECD, including 5q33.1-q35.2, 9p22.1-9p24.1, 13ptel-13q12.13 and 18q21.2-q21.32 [23] [24] [25] [26] . However, LOXHD1 (lipoxygenase homology domains 1) and TCF4 (transcription factor 4), which are both located on chromosome 18, are the only identified causative genes in these regions [18, 22] . In addition, several genes located in other regions are implicated in the pathogenesis of FECD, including ZEB1 (zinc finger E-box-binding homeobox 1), which is on chromosome 10, and SLC4A11 (sodium bicarbonate transporter-like protein 11), which is located at 20p12 [18, 25] . The results of many studies indicate that oxidative stress is strongly involved in the pathogenesis of KC and FECD [21, 27] . The cornea is constantly exposed to various exogenous agents known to cause oxidative stress, including UV radiation [28] . Reactive oxygen species (ROS) can react with many cellular components and damage them, leading to mutations, abnormal cell function or cell death. Under physiological conditions, various antioxidants eliminate ROS and prevent oxidative damage [29] . However, KC and FECD corneas exhibit a disturbance in the activity of their antioxidant enzymes [21, 30, 31] . ROS can affect DNA, generating single-strand breaks (SSBs), double-strand breaks (DSBs), mismatches, and chemical modifications of the DNA bases or sugarphosphate backbone [32] . Considerable oxidative DNA damage is repaired through the base excision repair (BER) mechanism [33] . In some cases, DNA damage induced by oxidative stress in the KC/FECD corneas can result from a change in the sequence of BER gene(s). In this study, we investigated the association between the c.444 T>G (rs1130409) and c.-468 T>G (rs1760944) polymorphisms in the APEX1 gene and KC/FECD occurrence. We also looked into the modulation of this association by some demographic and potential risk factors for KC/FECD. The APEX1 gene encodes human APEX nuclease 1 (APEX1), which is implicated in the recognition and processing of AP (apurinic/apyrimidinic) sites in BER. Therefore, genetic polymorphisms in this gene may contribute to changes in the DNA repair capacity, which may influence the development of corneal diseases.
MATERIALS AND METHODS

Study population
All of the patients and control subjects were recruited in the Department of Ophthalmology of the Medical University of Warsaw. The study was conducted on the ethnically homogeneous population of central Poland and involved 250 patients with KC, 209 patients with FECD and 350 individuals with FECD/KC exclusion (control subjects). Medical history was obtained from all of the subjects. None of them reported any genetic disease. KC diagnosis was based on clinical signs and topographical and pachymetric parameters assessed using TMS corneal topography and Orbscan examinations [1, 34, 35] . The map patterns were interpreted manually in all cases. Patients underwent ophthalmic examinations, including best-corrected visual acuity, intraocular pressure, slit lamp examination, fundus examination, corneal topography (TMS4, Tomey), Orbscan corneal topographical and pachymetrical maps (Orbscan IIz, Bausch & Lomb). FECD diagnosis was based on clinical signs in the slit lamp examination (occurrence of endothelial guttae, corneal edema). In all cases, the diagnosis in vivo confocal microscopy (IVCM) was used to confirm the presence of specific lesions, polymegathism and pleomorphism of the endothelial cells [36, 37] . Patients underwent ophthalmic examinations, including best-corrected visual acuity, intraocular pressure, slit lamp examination, fundus examination, IVCM and anterior segment optical coherence tomography, including pachymetry maps (AS-OCT). The IVCM was performed using a white light scanning slit confocal microscopy system (ConfoScan 3 or ConfoScan 4, Nidek Techologies). The AS-OCT was performed with a Swept Source Anterior Segment Casia OCT (Tomey). The control subjects had no clinical evidence of FECD or KC. They all had healthy corneal endothelia, as assessed using IVCM. They also had normal corneal topography and pachymetry. The Bioethics Committee of the Medical University of Warsaw approved the study and each subject gave written informed consent and was interviewed to obtain demographic data and information about potential risk factors for KC and FECD. All of the subjects provided information on their age, lifestyle, habits (including smoking), body mass index (BMI), allergies, co-occurrence of visual impairment (hyperopia, astigmatism, myopia), family history among first-degree relatives for KC or FECD, and heart or vascular diseases. Smoking was categorized as current smoker, former smoker or non-smoker (i.e., had never smoked). The characteristics of the patients and control subjects are presented in Tables 1 and 2 .
Selection of SNPs and primer design
Potentially functional polymorphisms in the DNA repair genes were obtained from the National Center for Biotechnology Information at http://www.ncbi.nlm.nih.gov/snp. We looked for SNPs that have a minor allele frequency (MAF) greater than 0.05 in Caucasians (submitter population ID: HapMap-CEU; http://www.ncbi.nlm.nih.gov/snp). For this study, we chose to genotype the c.444 T>G and the c.-468 T>G polymorphisms of the APEX1 gene. These SNPs have respective MAFs of 0.492 and 0.407 in the European population. Primers were designed according to the published nucleotide sequence in the ENSEMBL database (gene ID ENSG00000100823) and using Primer3 software (http://frodo.wi.mit.edu/). The primers used to detect the c.444 T>G SNP were: sense 5'-TAA TTC TGT TTC ATT TCT ATA GGC TA-3' (the underlined nucleotide is a mismatch to create a BfaI recognition site) and antisense 5'-TGC ATT AGG TAC ATA TGC TGT T-3'. PCR was performed under the following conditions: initial denaturation step at 95ºC for 5 min, 34 cycles at 95ºC for 30 s, 30 s at 58ºC (annealing temperature), 60 s extension at 72ºC, and the final extension step for 5 min at 72ºC. After amplification, the 108-bp PCR products containing the polymorphic site were digested with 3 U of BfaI restriction endonuclease (New England Biolabs) in a final volume of 15 μl for 16 h at 37ºC. The enzyme digests the G allele in the polymorphic site into two fragments of 83 and 25 bp, whereas fragments with a T at this site remained intact (Fig. 1) . The fragment of the APEX1 gene containing the c.-468 T>G polymorphic site was amplified via PCR using the following primer sequences: forward 5'-CTT ACA TTC GTA TCC GTT TTC CT-3' and reverse 5'-TGT GAC ACT GAC TTA AGA TTC TGA CT-3' (the underlined nucleotide is a mismatch to create an MlyI recognition site). The PCR profile contained an initial denaturation step at 95ºC for 5 min, 34 cycles at 95ºC for 30 s, 30 s at 55ºC (annealing temperature), extension for 60 s at 72ºC, and the final extension step for 5 min at 72ºC. Amplified fragments of 106 bp containing the polymorphic site were then digested with 2 U of MlyI restriction endonuclease (New England Biolabs, Ipswich, UK) in a final volume of 15 μl for 16 h at 37ºC. The G/G genotype produced two fragments (79 and 27 bp), the homozygote T/T only one fragment (106 bp), and the G/T genotype produced three fragments (106, 79 and 27 bp; Fig. 2 ). After digestion, the reaction mixture was separated on an 8% polyacrylamide gel. Electrophoresis was carried out at 5 V/cm in TBE buffer. A GeneRuler 100 bp (Fermentas) was used as a molecular mass marker. After separation, the gels were stained with ethidium bromide (0.5 mg/ml) and viewed in UV light. All of the PCR amplifications were conducted in a C1000 Thermal Cycler (Bio-Rad Laboratories). Positive and negative (no template) controls were included in all sets. For quality control, 10% of samples were randomly genotyped again. The results were 100% concordant.
Statistical analysis
Statistical analysis was performed using the SigmaPlot software, version 11.0 (Systat Software, Inc.). To compare the distributions of demographic variables and selected risk factors between patients and control subjects, the χ 2 test was used. The Hardy-Weinberg equilibrium was checked using the χ 2 test to compare the observed and expected genotype frequencies. The χ 2 test was also used to assess the significance of the differences between distributions of genotypes and alleles in KC/FECD patients and control subjects. The association between casecontrol status and each polymorphism, measured by the odds ratio (OR) and its corresponding 95% confidence interval (CI), was estimated using an unconditional multiple logistic regression model, both with and without adjustment for age, sex, co-occurrence of visual disturbances, heart and vascular diseases, allergies, and status of KC/FECD in the family. Haplotypes were assessed for each subject on the basis of known genotypes and the PHASE software (http://stephenslab.uchicago.edu/software.html). Haplotypes were analyzed in the same way as the genotypes of the polymorphisms. The power of the test applied to detect significant effects exceeded 90%.
RESULTS
Characteristics of the study subjects
The demographics and potential risk factors for KC and FECD for the study patients and control subjects are presented in Tables 1 and 2 . There were significant differences between the distributions of family history for KC/FECD (positive vs. negative family history), age, sex, co-occurrence of visual impairment (yes vs. no) between the KC and FECD patients and the control subjects. Patients with KC also showed significant differences between the distribution of the occurrence of heart and vascular diseases and allergies (yes vs. no) compared to the control group. These parameters were further adjusted in the multivariate logistic regression model for possible confounding factors of the main effect of the SNPs.
Relationship between age, sex, tobacco smoking, co-occurrence of visual disturbances, BMI, heart and vascular diseases, allergies and KC/FECD in the family and the risk of KC/FECD independently of genotype We assessed the relationship between age, sex, tobacco smoking, co-occurrence of visual disturbances, BMI, heart and vascular diseases, allergies and KC/FECD in the family and the risk of KC/FECD independently of genotype. We compared KC and FECD patients with control subjects according to these parameters (Tables 1 and 2 ). We found that male sex, KC in the family, cooccurrence of visual disturbances and allergies significantly increased KC occurrence, whereas age and co-occurrence of heart and vascular diseases decreased it. We also observed that female sex, age, FECD in the family and cooccurrence of visual disturbances significantly increased FECD occurrence.
The c.444 T>G and c.-468 T>G polymorphisms of the APEX1 gene and KC occurrence Table 3 shows the distribution of genotypes and allele frequencies of the c.444 T>G and c.-468 T>G polymorphisms of the APEX1 gene in KC patients and control subjects. The observed frequencies of genotypes in each SNP in all groups were in agreement with the predicted Hardy-Weinberg equilibrium values (p > 0.05, data not shown). There were significant differences in the frequency distributions of genotypes of these SNPs between the patients and control subjects. The presence of the G/T genotype of c.-468 T>G Table 4 . The observed genotype frequencies did not differ significantly from the Hardy-Weinberg equilibrium (p > 0.05; data not shown), and there was no difference in the frequency distributions of genotypes of these SNPs between patients and control subjects (p > 0.05). We did not find any association between the genotypes/alleles of these polymorphisms and the occurrence of FECD. 
Haplotypes and KC/FECD occurrence
We also investigated the association between the occurrence of KC/FECD and haplotypes of the c.444 T>G and c.-468 T>G polymorphisms of the APEX1 gene. The distribution of such haplotypes is shown in Table 5 . We did not observe a significant association between the haplotypes of the two polymorphisms and the occurrence of KC and FECD. 
DISCUSSION
Corneal cells are particularly susceptible to oxidative damage due to daily exposure to ROS-inducing environmental factors, including UV light and various chemicals, and the occurrence of ROS formed during normal metabolic processes [28] . Oxidative damage is implicated in the etiology of many pathological conditions, including ocular diseases [28, 40] . The pathogenesis of KC and FECD are poorly understood, but several studies indicate that they may include oxidative stress [21, 41] . Supporting evidence indicates that KC and FECD corneas display a decreased expression of genes encoding antioxidative enzymes that play a key role in ROS neutralization [21] . Moreover, KC and FECD corneas show an increased level of harmful products of lipid peroxidation and nitric oxide pathways [40] . A combination of several genetic factors with environmental and lifestyle aspects are probably implicated in the etiology of these diseases. We examined the relationship between clinical, environmental and lifestyle factors and the occurrence of KC and FECD independently of genotype. The analysis showed that a positive family history of KC and FECD had a significant influence. Previous reports showed a strong correlation between KC/FECD family history and KC/FECD occurrence [6] . We also observed a significant association between visual impairment, allergies, and heart and vascular diseases and KC. A significant correlation between visual impairment and FECD was noted. These results are generally in agreement with results obtained in other laboratories [41] [42] [43] . However, there is a substantial difference in the occurrence of heart and vascular diseases between KC patients and control subjects (Table 1) . This may be due to a significant difference between age distributions in these two groups, which raises the question whether this study was properly designed. As we mentioned in the Introduction, KC occurs in relatively young people, so in the general population, older individual have less chance of developing KC.
In other words, if we had age-matched the control subjects, the chance of late KC occurrence would be greater than in our current group of older individuals. It should be taken into account that it may be difficult to recruit hundreds of young people for time-consuming and uncomfortable thorough ophthalmic examinations and blood donation. However, this raises the next question about crosstalk between the elements of KC pathogenesis and age-related diseases.
It is especially important in light of recent work showing an association between DNA nucleotide excision repair and age-related vascular dysfunction [44] . This subject needs further research. In this paper, we adjusted our data on this difference in heart and vascular diseases occurrence.
In this study, we also checked the role of the APEX1 gene in KC and FECD. The involvement of oxidative damage in KC and FECD pathogenesis indicates a possible role of DNA repair genes. APEX1 is a multifunctional enzyme that plays a significant role in the repair of DNA damage, including oxidative DNA lesions, via the base excision repair (BER) pathway [33, 45] . APEX1 initiates repair of AP sites in DNA through hydrolysis of a 5'-phosphodiester bond of the AP site [39] . Besides major AP endonuclease activity, this enzyme has several other activities, including 3'-phosphodiesterase, 3'-phosphatase, and 3'-5' exonuclease [46, 47] . This enzyme also interacts with other BER enzymes, and thus is intimately involved in the coordination of BER pathway [45, 48] . In addition, APEX1 also has a role in the regulation of the expression of several genes, such as activator protein 1 (AP-1), nuclear factor-κB (NF-κB), hypoxiainducible factor 1α (HIF-1α), cAMP response element binding protein (CREB) and p53 [49] . The human APEX1 gene is located at 14q11.2 and contains five exons separated by four introns. To date, 164 SNPs of the APEX1 were reported in the public domain of the National Center for Biotechnology Information the Single Nucleotide Polymorphisms database (NCBI dbSNP; http://www.ncbi.nlm.nih.gov/snp). Among them, the c.444 T>G in the fifth exon and the c.-468 T>G in the promoter region have been most extensively studied. The c. 444 T>G polymorphism in APEX1 exon 5 leads to the Asp148Glu substitution. Functional studies indicated that the G allele in this polymorphism may impact the DNA-binding activity of BER proteins and reduce the interaction of APEX1 with these proteins, leading to decreased BER efficacy [50] . An in vitro promoter assay showed that the G allele of the c.-468 T>G polymorphism had a significantly higher transcriptional activity than T allele [51] . However, other studies reported lower APEX1 mRNA levels and impaired binding affinity of some transcription factors in the G allele, indicating that this allele may decrease APEX1-promoter activity [52] . Given the disparity between these functional studies, the role of this polymorphism should be further investigated. We observed a significant association between the G/T genotype of the c.-468 T>G polymorphism and decreased KC occurrence. In addition, the obtained results indicate that the T/T genotype in this polymorphic site is associated with an increased occurrence of KC. We did not detect any correlation between the genotypes/alleles of the c.444 T>G polymorphism and the frequency of occurrence of KC. The basic weakness of this study is that we concluded on an association between a disease and single genetic quantities, which were combined in the haplotype analysis. One of the main lessons from the Human Genome Project is that the expression of a single gene in our genome is associated with the expression of other genes, and sometimes a considerable number of genes. Therefore, a multigene approach, preferentially with a microarray, would be more suitable for our research. However, we do not know of any microarrays dedicated to KC/FECD containing DNA repair genes or at least base excision repair genes. To create such microarray, the genes should be preselected on the basis of an association study, which we have performed. Therefore, the genotype-phenotype relationship (KC/FECD) we obtained is rather vague. A correlation between genotype and APEX1 gene expression would be firmer, but it should be determined in the target tissue, the cornea, which is extremely difficult to obtain in control individuals. The results of our study suggest that the c. -468 T>G polymorphism of the APEX1 gene may have a role in KC pathogenesis, whereas the c.444 T>G and c.-468 T>G polymorphisms of this gene may not be associated with FECD.
